Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Clinical trial NCT05415098 · UNKNOWN

Trial details

NCT number: NCT05415098
Sponsor: Ascentage Pharma Group Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma Castrate Resistant Prostate Cancer Gastric Cancer Ovarian Clear Cell Carcinoma Mesothelioma Sarcoma Non Hodgkin Lymphoma B Cell Lymphoma Epithelioid Sarcoma

Start date: 2022-09-30
Primary completion: 2024-09-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.